Uma Sinha is CSO at Eidos Therapeutics, Inc. (EIDX). They have made 9 open-market trades across 2 companies since 2019, most recently 2022-07-11.
CIK 0001742587
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $238K since 2019, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EIDX | SELL | 2021-01-13 | 2021-01-15 | $124.17 | $2.2M | N/A | N/A | N/A |
| EIDX | SELL | 2020-12-02 | 2020-12-04 | $89.92 | $854K | +18.2% | +22.1% | N/A |
| EIDX | SELL | 2020-10-29 | 2020-10-30 | $72.31 | $456K | +5.6% | +29.8% | N/A |
| EIDX | SELL | 2020-09-30 | 2020-10-02 | $52.34 | $515K | +7.4% | +5.5% | +94.6% |
| EIDX | SELL | 2019-12-18 | 2019-12-20 | $61.90 | $1.5M | -7.7% | -11.4% | -28.6% |
| EIDX | SELL | 2019-09-25 | 2019-09-27 | $38.41 | $96K | -1.0% | +13.8% | +62.4% |
| EIDX | SELL | 2019-07-25 | 2019-07-29 | $35.95 | $286K | -4.1% | +30.0% | +25.2% |
| BBIO | BUY | 2019-07-01 | 2019-07-03 | $17.00 | $238K | -9.3% | -1.1% | -26.9% |
| EIDX | SELL | 2019-05-23 | 2019-05-28 | $27.28 | $136K | -1.8% | -6.0% | +43.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.